New drug combo trial offers hope for advanced colon cancer patients
NCT ID NCT07474727
Summary
This study is testing a new drug called AMT-676 in combination with standard chemotherapy drugs for people with advanced colorectal cancer that cannot be surgically removed. The main goals are to see if the combination is safe, what side effects occur, and whether it helps shrink tumors or slow cancer growth. About 180 participants will join this Phase 2 trial at multiple medical centers.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COLORECTAL CANCER are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.